Pia Kamstrup Articles
![How much reduction of Lp(a) is needed to translate into major clinical benefit? Setting the scene: Focus on PCSK9 inhibitors](https://www.pcsk9forum.org/wp-content/uploads/articleplaceholder-150x150.jpg)
How much reduction of Lp(a) is needed to translate into major clinical benefit? Setting the scene: Focus on PCSK9 inhibitors
Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board Pia Kamstrup
read more »Posted on 4 November 2022 |
Posted by Pia Kamstrup | Posted in News,
Hot topics,
17th Closed Scientific Expert Meeting of the Editorial Board
![Lp(a) as a cardiovascular risk factor – Is lowering Lp(a) beneficial when LDL is low?](https://www.pcsk9forum.org/wp-content/uploads/Screen-Shot-2018-06-28-at-11.39.15-1.png)
Lp(a) as a cardiovascular risk factor – Is lowering Lp(a) beneficial when LDL is low?
Reports from the 8th Expert Meeting of PCSK9 Forum Dr Pia Kamstrup
read more »Posted on 28 June 2018 |
Posted by Pia Kamstrup | Posted in Webcasts,
8th Closed Scientific Expert Meeting of the Editorial Board